Chronic Stroke PatientsNCT07715526
Comparıson of vırtual realıty-Based walkıng and treadmıll exercıse Effects on Balance and Balance ın Chronic Stroke
A study testing Virtual Reality-Based Walking Exercise and Treadmill Walking Exercise Group in people with Chronic Stroke Patients, run by Istinye University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to compare the effects of virtual reality-based walking exercises and treadmill walking exercises on balance, fear of falling, motor function, respiratory function, and fatigue in individuals who have had a stroke. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Chronic Stroke Patients
- What is being tested?
- Virtual Reality-Based Walking Exercise and Treadmill Walking Exercise Group
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 26 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Mar 2026to 29 Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Chronic stroke patients with hemiparesis (stroke >6 months post-stroke).
- Ages 18-75.
- No visual, auditory, or communication problems.
- No additional neurological, cardiovascular, orthopedic, etc. conditions causing balance problems. Mini-Mental State Assessment (MMSE) score ≥24
- Functional Ambulation Classification (FAS) level 4-5
- Impaired pulmonary function (FEV1/FVC <70% with spirometry)
- Providing informed consent and being a volunteer
- Speaking and understanding Turkish.
Who cannot join
- Peripheral occlusive arterial disease
- Uncontrolled hypertension (≥190/110 mmHg)
- History of epilepsy
- Inability to respond to visual and sensory stimuli
- Orthopedic problems restricting movement in the lower extremities
- Having undergone any botulinum toxin application or surgery within the last 6 months
- Having neglect syndrome or speech disorders
- Vestibular system problems or use of medications that may affect the vestibular system
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Istinye University
Istanbul, Zeytinburnu, 34275
About this study
Official title: Comparıson Of The Effects Of Vırtual Realıty-Based Walkıng Exercıse And Treadmıll Exercıse On Balance, Fear Of Fallıng, Motor And Respıratory Functıons, And Fatıgue In Patıents Wıth Chronıc Stroke
The aim of this study is to compare the effects of virtual reality-based walking exercises and treadmill walking exercises on balance, fear of falling, motor function, respiratory function, and fatigue in individuals who have had a stroke.
The main questions it aims to answer are:
Read more
How do virtual reality-based gait exercises and treadmill exercises affect balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke? H0: There is no statistically significant difference between virtual reality-based gait exercises and treadmill exercises in terms of their effects on balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke.
H1: There is a statistically significant difference between virtual reality-based gait exercises and treadmill exercises in terms of their effects on balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke.
Read the detailed description
This research will be conducted to determine the degree of difference between virtual reality-based walking exercises and treadmill walking exercises in individuals who have had a stroke, when comparing their effects on balance, fear of falling, motor function, respiratory function, and fatigue.
In this study, the data collection process will begin after participants sign a voluntary consent form. Following consent, a structured sociodemographic data form will be completed using face-to-face interviews to determine the sociodemographic characteristics of the participants. This form will record information such as gender, age, height, and weight.
The Mini Mental State Test will be used to assess eligibility for inclusion in the study. The Mini Mental State Test is a widely used, quick, and standardized measurement tool for assessing individuals' cognitive levels. The test covers different cognitive domains such as attention, memory, orientation, compliance with verbal and written instructions, copying complex shapes, and spontaneous sentence writing. The highest possible score on the test is 30, and cognitive levels are classified as low, medium, or high based on the scores obtained. The Turkish adaptation of the test will be used in this study.
Participants' respiratory functions will be assessed using a spirometer and a Pulmonary Function Test. Measurements will be administered before and after treatment, both assessment times, by the same researcher. Tests will be conducted in accordance with internationally accepted criteria for admissibility and reproducibility, and the test will be repeated until at least three valid results are obtained for each measurement. Individual characteristics of participants, such as age, gender, height, and body weight, will be considered in the evaluation of measurement results. Respiratory parameters to be recorded will include: forced expiratory volume in the first second, forced vital capacity, the ratio between these two parameters, peak expiratory flow, mid-expiratory flow rate, maximum voluntary ventilation, and vital capacity values.
To assess respiratory muscle strength, maximum inspiratory pressure and maximum expiratory pressure measurements will be taken using an intraoral pressure measuring device. Measurements will be performed according to a standard measurement protocol. During maximum inspiratory pressure measurement, the participant will be in an upright seated position, a nasal clip will be used to prevent air passage through the nose, and the mouthpiece will be positioned to prevent air leakage. The participant will be asked to perform a maximum inspiration lasting at least 1.5 seconds after maximum expiration. The measurement will be repeated three times, and the highest value obtained will be recorded. Results will be expressed in centimeters of water pressure.
Similarly, for maximum expiratory pressure measurement, the participant will be in an upright seated position, a nose clip will be applied, and the mouthpiece will be properly positioned. The participant will be asked to perform a maximum expiration lasting at least 1.5 seconds after a maximum inspiration. The measurement will be performed three times, and the highest value will be recorded. Measurement results will be expressed in centimeters of water pressure.
The Timed Up and Walk Test will be used to assess participants' functional capacity. Before the test, participants will be given a detailed explanation of how the test will be administered. The participant will start in a seated position in a standard chair and walk to a marked point three meters away from the chair. After reaching the marked point, they will turn 180 degrees, return to the chair, and complete the test while seated. The stopwatch will be started the moment the participant gets up and stopped the moment they sit down again. The test will be administered three times, and the shortest time obtained will be evaluated.
The Functional Independence Scale will be used to assess functional independence. This scale is a comprehensive measurement tool that assesses the level of independence individuals can achieve in daily living activities. The scale consists of 18 items covering physical and cognitive functions. Physical functions include sub-areas of self-care, sphincter control, transference, and movement; while cognitive functions encompass communication and social-cognitive domains. Each item is scored between 1 and 7, with higher scores indicating a higher level of independence. The Turkish version of the scale will be used in this study.
The International Fall Activity Scale will be used to assess participants' levels of fear of falling. This scale consists of 16 items that question individuals' levels of anxiety regarding falls during daily living activities. Each item is evaluated using a four-point scoring system, with total scores ranging from 16 to 64. Higher scores indicate a higher level of fear of falling.
The Functional Ambulation Classification will be used to assess ambulation levels. This classification system rates individuals' walking levels on a scale of 0 to 5. Low scores indicate the absence of ambulation or dependence on external support, while high scores indicate that the individual can walk independently.
Walking speed will be assessed using the 10-Meter Walk Test. During the test, participants will be asked to walk from a designated starting point to a finish point at a normal walking speed. The distance covered and time elapsed will be recorded, and the walking speed will be calculated in meters per second.
The Fugl-Meyer Motor Assessment Scale will be used to assess motor functions. The scale has a rating system where each parameter is scored as unsuccessful, partially successful, or completely successful. Motor and sensory sections, which assess upper and lower extremity motor functions, will be used. Higher scores indicate better motor and sensory function levels. This scale is a valid and reliable measurement tool widely used in the assessment of paretic extremities in individuals who have experienced a stroke.
In this study, participants will be divided into intervention groups that include conventional physiotherapy along with different gait training approaches.
Conventional Physiotherapy Application
The conventional physiotherapy program will be applied for six weeks, five days a week. Each session will last thirty minutes. The treatment will include passive, active assistive, and active range of motion exercises for the lower extremities. Strengthening exercises to strengthen the muscle groups that aid in walking will be included in the program. Balance and coordination-focused exercises such as walking on different surfaces, obstacle course, and tandem walking will be applied to support balance development. Following the conventional physiotherapy application, electrical stimulation will be applied to the quadriceps and tibialis anterior muscles, which play a significant role in gait function, for fifteen minutes using an electrical stimulation device.
Virtual Reality-Based Gait Training Group
Participants in this group will receive virtual reality-based gait training in addition to conventional physiotherapy. The intervention will be conducted five days a week for six weeks, with each session lasting forty-five minutes. As part of the virtual reality application, participants will wear virtual reality glasses and perform walking exercises for fifteen minutes accompanied by three-dimensional video content simulating a nature walk.
Treadmill Walking Exercise Group
Participants in this group will receive treadmill walking exercises in addition to conventional physiotherapy. The intervention will last six weeks, five days a week, with each session lasting forty-five minutes. The walking speed on the treadmill will be determined individually based on the results of a ten-meter walk test administered at the beginning of the study. Participants will perform treadmill walking exercises for fifteen minutes at the determined speed.
- Conditions
- Chronic Stroke Patients
- Being tested
- Virtual Reality-Based Walking Exercise, Treadmill Walking Exercise Group
- Keywords
- chronic stroke, virtual reality, balance, fear of falling, motor function, respiratory function, fatigue, physiotherapy and rehabilitation, neurological rehabilitation
- Medical subject headings
- Respiratory Aspiration, Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual Reality-Based Walking ExerciseOther
Conventional physiotherapy + VR Therapy / 45 min, 5 sessions per week / 6 weeks The patient will be shown a 3D video including a 15-minute nature walk while wearing virtual reality glasses.
Treadmill Walking Exercise GroupOther
Conventional physical therapy + Treadmill / 45 min per week 5 sessions/6 weeks Walking speed will be calculated based on a 10-meter walking test performed at the start of the study; patients will perform a 15-minute walking exercise on the treadmill.
| Study group | Role | What they receive |
|---|---|---|
| Virtual Reality-Based Walking Exercise Group | Active comparator | Conventional physiotherapy + VR (virtual reality) Therapy / 45 min, 5 sessions per week / 6 weeks The patient will be shown a 3D video including a 15-minute nature walk while wearing virtual reality glasses. Receives: Other: Virtual Reality-Based Walking Exercise |
| Treadmill Walking Exercise Group | Active comparator | Conventional physiotherapy + Treadmill / 45 min per week 5 sessions/6 weeks Walking speed will be calculated based on the 10-meter walking test performed at the beginning of the study; patients will then perform 15-minute walking exercises on the treadmill. Receives: Other: Treadmill Walking Exercise Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Respiratory Outcome Measures - Volume (L)
Respiratory parameters will be assessed at baseline and Week 6 using a COSMED PONY spirometer, with the best of three acceptable attempts recorded for each measure. The primary spirometric outcomes in this category include FEV1 (L), FVC (L), and VC (L).
Measured: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Respiratory Outcome Measures - Ratio (%)
The FEV1/FVC ratio (%) will be recorded as a separate spirometric outcome.
Measured: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Respiratory Outcome Measures - Flow Rate (L/min)
Peak expiratory flow (PEF) and maximum voluntary ventilation (MVV) will be measured in L/min.
Measured: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Respiratory Outcome Measures - Flow Rate (L/s)
Forced expiratory flow at 25-75% of the pulmonary volume (FEF 25-75%) will be measured in L/s.
Measured: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Respiratory Outcome Measures - Pressure (cmH₂O)
Maximum inspiratory and expiratory pressures (MIP and MEP) will be measured using a pressure manometer with a nasal clip, with the highest of three attempts recorded in cmH₂O.
Measured: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Secondary outcomes (6)
EVALUATION OF MOTOR FUNCTIONS
Motor function will be assessed at baseline and Week 6 using the upper and lower extremity subscales of the Fugl-Meyer Motor Assessment Scale (FMA). Each item is scored 0-2, with higher scores indicating better function. The upper extremity subscale ranges from 0 to 66 points, and the lower extremity subscale ranges from 0 to 34 points.
Measured: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FEAR OF FALLING
Assessed using the International Fall Activity Scale. Consists of 16 items scored from 1 (no anxiety) to 4 (a lot of anxiety). Total score ranges from 16 to 64, with higher scores indicating greater fear. Measured on a scale (16-64 points).
Measured: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FUNCTIONAL INDEPENDENCE
Assessed using the Functional Independence Measure (total score). Comprises 18 items (13 motor, 5 cognitive), each scored 1-7. Total score ranges from 18 to 126, with higher scores indicating greater independence. Measured on a scale (18-126 points).
Measured: UNTIL THE END OF 6 WEEKS OF TREATMENT
EVALUATION OF FUNCTIONAL AMBULATION
Assessed using the Functional Ambulation Classification. A 6-level ordinal scale ranging from 0 (non-ambulatory) to 5 (ambulatory). Measured on a scale (0-5 points).
Measured: UNTIL THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FUNCTIONAL CAPACITY
Assessed using the Timed Up and Go Test. The participant rises from a chair, walks 3 meters, turns, returns, and sits down. The test is administered three times, and the shortest time is recorded. Measured in seconds (s).
Measured: UNTIL THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FATIGUE
Assessed using the Modified Borg Category-Rate (CR10) Scale. Participants rate their perceived exertion from 0 (no exertion) to 10 (maximum exertion). Measured on a scale (0-10 points).
Measured: UNTIL THE END OF 6 WEEKS OF TREATMENT
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2026
- Study start15 Mar 2026
- Primary completion15 Apr 2026
- Study completion29 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Stroke PatientsStudies of the same condition, open and under way.
- More trials run by Istinye UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Two groups and additional conventional physiotherapy applications.
- Masking
- None (open label)
- Enrolment
- 26 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istinye University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gökay Küçükyılmaz, Istinye University
- Investigators
- Gokay KUCUKYILMAZ, BSc, Principal investigator, Istinye University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07715526
- Sponsor's protocol ID
- 25-127
- Status last verified
- Jul 2026
- First submitted
- 14 Jan 2026
- Last updated
- 20 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: personal rights protection law
Study at a glance
From the registry record, last updated by the sponsor on 20 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparıson Of The Effects Of Vırtual Realıty-Based Walkıng Exercıse And Treadmıll Exercıse On Balance, Fear Of Fallıng, Motor And Respıratory Functıons, And Fatıgue In Patıents Wıth Chronıc Stroke
- ClinicalTrials.gov ID
- NCT07715526
- Acronym / sponsor ID
- 25-127
- Conditions
- Chronic Stroke Patients
- Keywords
- chronic stroke, virtual reality, balance, fear of falling, motor function, respiratory function, fatigue, physiotherapy and rehabilitation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Istinye UniversityUniversity, hospital or other
- Study start
- 15 Mar 2026 (actual)
- Primary completion
- 15 Apr 2026 (actual)
- Study completion
- 29 Jun 2026 (actual)
- First posted
- 20 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to compare the effects of virtual reality-based walking exercises and treadmill walking exercises on balance, fear of falling, motor function, respiratory function, and fatigue in individuals who have had a stroke.
The main questions it aims to answer are:
How do virtual reality-based gait exercises and treadmill exercises affect balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke? H0: There is no statistically significant difference between virtual reality-based gait exercises and treadmill exercises in terms of their effects on balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke.
H1: There is a statistically significant difference between virtual reality-based gait exercises and treadmill exercises in terms of their effects on balance, fear of falling, motor and respiratory functions, and fatigue in patients with chronic stroke.
Detailed description
This research will be conducted to determine the degree of difference between virtual reality-based walking exercises and treadmill walking exercises in individuals who have had a stroke, when comparing their effects on balance, fear of falling, motor function, respiratory function, and fatigue.
In this study, the data collection process will begin after participants sign a voluntary consent form. Following consent, a structured sociodemographic data form will be completed using face-to-face interviews to determine the sociodemographic characteristics of the participants. This form will record information such as gender, age, height, and weight.
The Mini Mental State Test will be used to assess eligibility for inclusion in the study. The Mini Mental State Test is a widely used, quick, and standardized measurement tool for assessing individuals' cognitive levels. The test covers different cognitive domains such as attention, memory, orientation, compliance with verbal and written instructions, copying complex shapes, and spontaneous sentence writing. The highest possible score on the test is 30, and cognitive levels are classified as low, medium, or high based on the scores obtained. The Turkish adaptation of the test will be used in this study.
Participants' respiratory functions will be assessed using a spirometer and a Pulmonary Function Test. Measurements will be administered before and after treatment, both assessment times, by the same researcher. Tests will be conducted in accordance with internationally accepted criteria for admissibility and reproducibility, and the test will be repeated until at least three valid results are obtained for each measurement. Individual characteristics of participants, such as age, gender, height, and body weight, will be considered in the evaluation of measurement results. Respiratory parameters to be recorded will include: forced expiratory volume in the first second, forced vital capacity, the ratio between these two parameters, peak expiratory flow, mid-expiratory flow rate, maximum voluntary ventilation, and vital capacity values.
To assess respiratory muscle strength, maximum inspiratory pressure and maximum expiratory pressure measurements will be taken using an intraoral pressure measuring device. Measurements will be performed according to a standard measurement protocol. During maximum inspiratory pressure measurement, the participant will be in an upright seated position, a nasal clip will be used to prevent air passage through the nose, and the mouthpiece will be positioned to prevent air leakage. The participant will be asked to perform a maximum inspiration lasting at least 1.5 seconds after maximum expiration. The measurement will be repeated three times, and the highest value obtained will be recorded. Results will be expressed in centimeters of water pressure.
Similarly, for maximum expiratory pressure measurement, the participant will be in an upright seated position, a nose clip will be applied, and the mouthpiece will be properly positioned. The participant will be asked to perform a maximum expiration lasting at least 1.5 seconds after a maximum inspiration. The measurement will be performed three times, and the highest value will be recorded. Measurement results will be expressed in centimeters of water pressure.
The Timed Up and Walk Test will be used to assess participants' functional capacity. Before the test, participants will be given a detailed explanation of how the test will be administered. The participant will start in a seated position in a standard chair and walk to a marked point three meters away from the chair. After reaching the marked point, they will turn 180 degrees, return to the chair, and complete the test while seated. The stopwatch will be started the moment the participant gets up and stopped the moment they sit down again. The test will be administered three times, and the shortest time obtained will be evaluated.
The Functional Independence Scale will be used to assess functional independence. This scale is a comprehensive measurement tool that assesses the level of independence individuals can achieve in daily living activities. The scale consists of 18 items covering physical and cognitive functions. Physical functions include sub-areas of self-care, sphincter control, transference, and movement; while cognitive functions encompass communication and social-cognitive domains. Each item is scored between 1 and 7, with higher scores indicating a higher level of independence. The Turkish version of the scale will be used in this study.
The International Fall Activity Scale will be used to assess participants' levels of fear of falling. This scale consists of 16 items that question individuals' levels of anxiety regarding falls during daily living activities. Each item is evaluated using a four-point scoring system, with total scores ranging from 16 to 64. Higher scores indicate a higher level of fear of falling.
The Functional Ambulation Classification will be used to assess ambulation levels. This classification system rates individuals' walking levels on a scale of 0 to 5. Low scores indicate the absence of ambulation or dependence on external support, while high scores indicate that the individual can walk independently.
Walking speed will be assessed using the 10-Meter Walk Test. During the test, participants will be asked to walk from a designated starting point to a finish point at a normal walking speed. The distance covered and time elapsed will be recorded, and the walking speed will be calculated in meters per second.
The Fugl-Meyer Motor Assessment Scale will be used to assess motor functions. The scale has a rating system where each parameter is scored as unsuccessful, partially successful, or completely successful. Motor and sensory sections, which assess upper and lower extremity motor functions, will be used. Higher scores indicate better motor and sensory function levels. This scale is a valid and reliable measurement tool widely used in the assessment of paretic extremities in individuals who have experienced a stroke.
In this study, participants will be divided into intervention groups that include conventional physiotherapy along with different gait training approaches.
Conventional Physiotherapy Application
The conventional physiotherapy program will be applied for six weeks, five days a week. Each session will last thirty minutes. The treatment will include passive, active assistive, and active range of motion exercises for the lower extremities. Strengthening exercises to strengthen the muscle groups that aid in walking will be included in the program. Balance and coordination-focused exercises such as walking on different surfaces, obstacle course, and tandem walking will be applied to support balance development. Following the conventional physiotherapy application, electrical stimulation will be applied to the quadriceps and tibialis anterior muscles, which play a significant role in gait function, for fifteen minutes using an electrical stimulation device.
Virtual Reality-Based Gait Training Group
Participants in this group will receive virtual reality-based gait training in addition to conventional physiotherapy. The intervention will be conducted five days a week for six weeks, with each session lasting forty-five minutes. As part of the virtual reality application, participants will wear virtual reality glasses and perform walking exercises for fifteen minutes accompanied by three-dimensional video content simulating a nature walk.
Treadmill Walking Exercise Group
Participants in this group will receive treadmill walking exercises in addition to conventional physiotherapy. The intervention will last six weeks, five days a week, with each session lasting forty-five minutes. The walking speed on the treadmill will be determined individually based on the results of a ten-meter walk test administered at the beginning of the study. Participants will perform treadmill walking exercises for fifteen minutes at the determined speed.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Two groups and additional conventional physiotherapy applications.
| Arm | Type | Receives |
|---|---|---|
| Virtual Reality-Based Walking Exercise Group | Active comparator | Other: Virtual Reality-Based Walking ExerciseConventional physiotherapy + VR (virtual reality) Therapy / 45 min, 5 sessions per week / 6 weeks The patient will be shown a 3D video including a 15-minute nature walk while wearing virtual reality glasses. |
| Treadmill Walking Exercise Group | Active comparator | Other: Treadmill Walking Exercise GroupConventional physiotherapy + Treadmill / 45 min per week 5 sessions/6 weeks Walking speed will be calculated based on the 10-meter walking test performed at the beginning of the study; patients will then perform 15-minute walking exercises on the treadmill. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Chronic stroke patients with hemiparesis (stroke >6 months post-stroke).
- Ages 18-75.
- No visual, auditory, or communication problems.
- No additional neurological, cardiovascular, orthopedic, etc. conditions causing balance problems. Mini-Mental State Assessment (MMSE) score ≥24
- Functional Ambulation Classification (FAS) level 4-5
Key exclusion criteria (8 listed)
- Peripheral occlusive arterial disease
- Uncontrolled hypertension (≥190/110 mmHg)
- History of epilepsy
- Inability to respond to visual and sensory stimuli
- Orthopedic problems restricting movement in the lower extremities
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual Reality-Based Walking ExerciseConventional physiotherapy + VR Therapy / 45 min, 5 sessions per week / 6 weeks The patient will be shown a 3D video including a 15-minute nature walk while wearing virtual reality glasses. | Other | Virtual Reality-Based Walking Exercise Group |
| Treadmill Walking Exercise GroupConventional physical therapy + Treadmill / 45 min per week 5 sessions/6 weeks Walking speed will be calculated based on a 10-meter walking test performed at the start of the study; patients will perform a 15-minute walking exercise on the treadmill. | Other | Treadmill Walking Exercise Group |
Primary outcome
Respiratory Outcome Measures - Volume (L)
Time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Respiratory parameters will be assessed at baseline and Week 6 using a COSMED PONY spirometer, with the best of three acceptable attempts recorded for each measure. The primary spirometric outcomes in this category include FEV1 (L), FVC (L), and VC (L).
Respiratory Outcome Measures - Ratio (%)
Time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
The FEV1/FVC ratio (%) will be recorded as a separate spirometric outcome.
Respiratory Outcome Measures - Flow Rate (L/min)
Time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Peak expiratory flow (PEF) and maximum voluntary ventilation (MVV) will be measured in L/min.
Respiratory Outcome Measures - Flow Rate (L/s)
Time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Forced expiratory flow at 25-75% of the pulmonary volume (FEF 25-75%) will be measured in L/s.
Respiratory Outcome Measures - Pressure (cmH₂O)
Time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
Maximum inspiratory and expiratory pressures (MIP and MEP) will be measured using a pressure manometer with a nasal clip, with the highest of three attempts recorded in cmH₂O.
6 secondary outcomes
EVALUATION OF MOTOR FUNCTIONS
Time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FEAR OF FALLING
Time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FUNCTIONAL INDEPENDENCE
Time frame: UNTIL THE END OF 6 WEEKS OF TREATMENT
EVALUATION OF FUNCTIONAL AMBULATION
Time frame: UNTIL THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FUNCTIONAL CAPACITY
Time frame: UNTIL THE END OF 6 WEEKS OF TREATMENT
ASSESSMENT OF FATIGUE
Time frame: UNTIL THE END OF 6 WEEKS OF TREATMENT
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jul 2026.
- Individual participant dataSharing planned: No. personal rights protection law
Related trials for Chronic Stroke Patients
Recruiting
Effect of Anomia Rehabilitation Combined With Metacognitive Training in Patients With Chronic Vascular Aphasia
Aphasia, Stroke
Not yet recruiting
Effects of Jaw Clenching on Gait and Mobility in Stroke
Stroke
Not yet recruiting
Foot Drop Rehabilitation and Mobility in Chronic Stroke
Stroke
Recruiting
Functional Improvement in Subacute/Chronic Stroke Through Non-invasive Virtual-reality-Based Telerehabilitation
Stroke
Not yet recruitingPhase 2
Rimonabant for Improving Walking Ability in Patients With Chronic Stroke
Chronic Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gokay KUCUKYILMAZ, BSc principal investigator
Istinye University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual Reality-Based Walking Exercise and Treadmill Walking Exercise Group in people with Chronic Stroke Patients, run by Istinye University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Respiratory Outcome Measures - Volume (L) (time frame: FROM REGISTRATION TO THE END OF 6 WEEKS OF TREATMENT). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026.